Short description
Serenex is a drug discovery and development company focused on oncology.
Description
Serenex is a medical drug discovery and development company that focuses on oncology. The company develops Hsp90 product platform that provides a collection of small molecule Hsp90 inhibitors for cancer, inflammatory diseases, fungal infection resistance, viral diseases, and neurodegenerative diseases, such as Alzheimer's. It also develops SNX-1012, a product for oral mucositis in solid tumor patients.
Serenex is a U.S.-based company that was founded in 2000 and it was acquired in 2008 by Pfizer.
Last funding
Noaccess
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Durham, North Carolina, United States, North America
Founded on
January 1, 2000
Exited on
March 3, 2008
Non-profit?
No
Acquired?
No
Employees count
11-50
Investors
Noaccess, Uh Ohhhh, Noaccess, No Way, Noway Youcantaccess, Nopepepe, Blurry Noaccess, Noaccess, Noway Youcantaccess, Noway Youcantaccess, No Way, Absolutely Noaccess, Absolutely Noaccess
Sign in for full access